Global Viral Inactivation Market by Product (Kits & Reagents, Services, Viral Inactivation Systems & Accessories), Method (Pasteurization, Solvent Detergent Method), Application, End User - Forecast 2024-2030- Product Image

Sale

Global Viral Inactivation Market by Product (Kits & Reagents, Services, Viral Inactivation Systems & Accessories), Method (Pasteurization, Solvent Detergent Method), Application, End User - Forecast 2024-2030

Report
192 Pages
March 2024
Region: Global
360iResearch™
ID: 4986084

UP TO €844EUR$875USD£724GBP OFF until Dec 31^st 2024

The Viral Inactivation Market size was estimated at USD 977.41 million in 2023, USD 1,119.48 million in 2024, and is expected to grow at a CAGR of 14.62% to reach USD 2,541.74 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Viral Inactivation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Viral Inactivation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Viral Inactivation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Cytiva by Danaher Corporation, Eurofins Scientific (Ireland) Limited, HiMedia Laboratories, LLC, Lonza Group Ltd., Merck KGaA, Parker Hannifin Corporation, PromoCell GmbH, Rad Source Technologies, Inc., Sartorius AG, Thermo Fisher Scientific Inc, and WuXi AppTec Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Viral Inactivation Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Kits & Reagents
- Services
- Viral Inactivation Systems & Accessories
Method
- Pasteurization
- Solvent Detergent Method
Application
- Blood & Blood Product
- Cellular & Gene Therapy Product
- Stem Cell Product
- Tissues & Tissue Product
- Vaccines & Therapeutic
End User
- Academic Research Institutes
- Contract Research Organizations
- Pharmaceutical & Biotechnology Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Viral Inactivation Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Viral Inactivation Market?
What are the technology trends and regulatory frameworks in the Viral Inactivation Market?
What is the market share of the leading vendors in the Viral Inactivation Market?
Which modes and strategic moves are suitable for entering the Viral Inactivation Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Viral Inactivation Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the global prevalence of chronic diseases
5.1.1.2. Growing government support for pharmaceutical & biotechnology industries
5.1.1.3. Rising number of new drug approvals
5.1.2. Restraints
5.1.2.1. High costs associated with the manufacture of biosimilar products
5.1.3. Opportunities
5.1.3.1. Technological integrations in viral inactivation procedures
5.1.3.2. Strong R&D investments in the life sciences industry
5.1.4. Challenges
5.1.4.1. Strict government regulatory guidelines
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Viral Inactivation Market, by Product

6.1. Introduction
6.2. Kits & Reagents
6.3. Services
6.4. Viral Inactivation Systems & Accessories

7. Viral Inactivation Market, by Method

7.1. Introduction
7.2. Pasteurization
7.3. Solvent Detergent Method

8. Viral Inactivation Market, by Application

8.1. Introduction
8.2. Blood & Blood Product
8.3. Cellular & Gene Therapy Product
8.4. Stem Cell Product
8.5. Tissues & Tissue Product
8.6. Vaccines & Therapeutic

9. Viral Inactivation Market, by End User

9.1. Introduction
9.2. Academic Research Institutes
9.3. Contract Research Organizations
9.4. Pharmaceutical & Biotechnology Companies

10. Americas Viral Inactivation Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Viral Inactivation Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Viral Inactivation Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Agilent Technologies, Inc.
14.1.2. Becton, Dickinson and Company
14.1.3. Bio-Rad Laboratories, Inc.
14.1.4. Charles River Laboratories International, Inc.
14.1.5. Cytiva by Danaher Corporation
14.1.6. Eurofins Scientific (Ireland) Limited
14.1.7. HiMedia Laboratories, LLC
14.1.8. Lonza Group Ltd.
14.1.9. Merck KGaA
14.1.10. Parker Hannifin Corporation
14.1.11. PromoCell GmbH
14.1.12. Rad Source Technologies, Inc.
14.1.13. Sartorius AG
14.1.14. Thermo Fisher Scientific Inc
14.1.15. WuXi AppTec Co., Ltd.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. VIRAL INACTIVATION MARKET RESEARCH PROCESS
FIGURE 2. VIRAL INACTIVATION MARKET SIZE, 2023 VS 2030
FIGURE 3. VIRAL INACTIVATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VIRAL INACTIVATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. VIRAL INACTIVATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VIRAL INACTIVATION MARKET DYNAMICS
FIGURE 7. VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
FIGURE 10. VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. VIRAL INACTIVATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. VIRAL INACTIVATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. VIRAL INACTIVATION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. VIRAL INACTIVATION MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. VIRAL INACTIVATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. VIRAL INACTIVATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. VIRAL INACTIVATION MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VIRAL INACTIVATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. VIRAL INACTIVATION MARKET SIZE, BY VIRAL INACTIVATION SYSTEMS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 10. VIRAL INACTIVATION MARKET SIZE, BY PASTEURIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. VIRAL INACTIVATION MARKET SIZE, BY SOLVENT DETERGENT METHOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. VIRAL INACTIVATION MARKET SIZE, BY BLOOD & BLOOD PRODUCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. VIRAL INACTIVATION MARKET SIZE, BY CELLULAR & GENE THERAPY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. VIRAL INACTIVATION MARKET SIZE, BY STEM CELL PRODUCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. VIRAL INACTIVATION MARKET SIZE, BY TISSUES & TISSUE PRODUCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. VIRAL INACTIVATION MARKET SIZE, BY VACCINES & THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. VIRAL INACTIVATION MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. VIRAL INACTIVATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. CANADA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. CANADA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 37. CANADA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. CANADA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. MEXICO VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. MEXICO VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 41. MEXICO VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. MEXICO VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. CHINA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. CHINA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 59. CHINA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. CHINA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. INDIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. INDIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 63. INDIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. INDIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. JAPAN VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. JAPAN VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 71. JAPAN VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. JAPAN VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. THAILAND VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. THAILAND VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 95. THAILAND VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. THAILAND VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. DENMARK VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. DENMARK VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 108. DENMARK VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. DENMARK VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. EGYPT VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. EGYPT VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 112. EGYPT VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. EGYPT VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. FINLAND VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. FINLAND VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 116. FINLAND VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. FINLAND VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. FRANCE VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. FRANCE VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 120. FRANCE VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. FRANCE VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. GERMANY VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. GERMANY VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 124. GERMANY VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. GERMANY VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. ITALY VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. ITALY VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 132. ITALY VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ITALY VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. NORWAY VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. NORWAY VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 144. NORWAY VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. NORWAY VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. POLAND VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. POLAND VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 148. POLAND VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. POLAND VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. QATAR VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. QATAR VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 152. QATAR VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. QATAR VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. SPAIN VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. SPAIN VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 168. SPAIN VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SPAIN VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. TURKEY VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. TURKEY VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 180. TURKEY VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. TURKEY VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. VIRAL INACTIVATION MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 191. VIRAL INACTIVATION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 192. VIRAL INACTIVATION MARKET LICENSE & PRICING

Companies Mentioned

Agilent Technologies, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Charles River Laboratories International, Inc.
Cytiva by Danaher Corporation
Eurofins Scientific (Ireland) Limited
HiMedia Laboratories, LLC
Lonza Group Ltd.
Merck KGaA
Parker Hannifin Corporation
PromoCell GmbH
Rad Source Technologies, Inc.
Sartorius AG
Thermo Fisher Scientific Inc
WuXi AppTec Co., Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	192
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1119.48 Million
Forecasted Market Value ( USD ) by 2030	$ 2541.74 Million
Compound Annual Growth Rate	14.6%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3257EUR$3,374USD£2,794GBP €3619EUR$3,749USD£3,104GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4125EUR$4,274USD£3,539GBP €4584EUR$4,749USD£3,932GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4994EUR$5,174USD£4,284GBP €5549EUR$5,749USD£4,760GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5863EUR$6,074USD£5,029GBP €6514EUR$6,749USD£5,588GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7600EUR$7,874USD£6,519GBP €8445EUR$8,749USD£7,244GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Viral Inactivation Market Report and Forecast 2023-2031

Viral Inactivation: Global Strategic Business Report

Viral Inactivation Global Market Report 2024

Detergent Viral Inactivation Product Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Viral Inactivation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

About the Viral Inactivation Market